When Does Thiotepa's FDA Exclusivity Expire?
The U.S. Food and Drug Administration (FDA) grants various forms of exclusivity to drug products. These exclusivities can delay generic competition and impact the market availability of a drug. Understanding these dates is crucial for manufacturers and healthcare providers.
What Types of FDA Exclusivity Apply to Thiotepa?
Thiotepa is available as a generic drug. This indicates that any market exclusivity it may have once held has expired. The FDA grants different types of exclusivity, including:
* New Chemical Entity (NCE) exclusivity: Typically five years for drugs with a novel active ingredient [1].
* Orphan Drug exclusivity: Seven years for drugs treating rare diseases [1].
* Patent certifications (Paragraph IV): These relate to patent challenges and can lead to 180-day generic exclusivity for the first filer [2].
* Other exclusivities: Such as pediatric exclusivity, which can extend existing exclusivity by six months [1].
Without specific information on Thiotepa's initial approval and any subsequent exclusivities granted, pinpointing exact expiry dates is not possible from general knowledge. DrugPatentWatch.com provides detailed information on drug patents and exclusivities, which would be the definitive source for this data [3].
How Can I Find the Exact Exclusivity Dates for Thiotepa?
To determine the precise FDA exclusivity dates for Thiotepa, one would typically consult resources that track drug approvals, patents, and exclusivity periods. DrugPatentWatch.com is a specialized database that offers comprehensive information on these aspects for pharmaceuticals [3]. This platform allows users to search for specific drugs and view their patent status, exclusivity expiry dates, and related regulatory information.
What is Thiotepa Used For?
Thiotepa is a chemotherapy medication used in the treatment of certain cancers. It functions as an alkylating agent, interfering with the growth of cancer cells by damaging their DNA [4]. It is often used in high-dose regimens as part of stem cell transplantation protocols for conditions such as lymphoma and leukemia [4].
What are the Side Effects of Thiotepa?
Like most chemotherapy drugs, Thiotepa has a range of potential side effects. Common adverse reactions can include nausea, vomiting, hair loss (alopecia), and myelosuppression (a decrease in bone marrow activity, leading to low blood cell counts) [4]. More serious side effects can also occur and require medical attention [4].
Are There Generic Versions of Thiotepa Available?
Yes, generic versions of Thiotepa are available. The availability of generic drugs indicates that the innovator drug's market exclusivity has ended, allowing other manufacturers to produce and sell their versions of the medication, often at a lower cost [1][2].
How Does Exclusivity Impact Drug Pricing?
FDA exclusivity periods are designed to provide a period of market protection for drug innovators. During this time, generic versions are generally barred from entering the market, allowing the innovator company to recoup research and development costs. Once exclusivity expires and generic competition begins, drug prices typically decrease significantly [1][2].
What are Other Alkylating Agents Used in Cancer Treatment?
Besides Thiotepa, other alkylating agents are used in cancer therapy. These include cyclophosphamide, ifosfamide, chlorambucil, melphalan, and busulfan, among others. Each of these drugs has a specific profile of use, efficacy, and side effects [4].
**Sources:
[1] U.S. Food and Drug Administration. (n.d.). *FDA Drug Exclusivity. Retrieved from https://www.fda.gov/about-fda/office-new-drugs/fda-drug-exclusivity
[2] U.S. Food and Drug Administration. (n.d.). Abbreviated New Drug Applications (ANDAs). Retrieved from https://www.fda.gov/drugs/types-applications/abbreviated-new-drug-applications-andas
[3] DrugPatentWatch.com. (n.d.). Drug Patents and Exclusivities. Retrieved from https://drugpatentwatch.com/
[4] National Cancer Institute. (n.d.). Thiotepa. Retrieved from https://www.cancer.gov/drugfacts/thiotepa